3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
33
Colorectal Neoplasms
13
Neoplasms
11
Pain, Postoperative
10
Lung Neoplasms
9
Brain Neoplasms
8
Stomach Neoplasms
7
Prostatic Neoplasms
7
Pancreatic Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Melanoma
6
Leukemia, Myeloid, Acute
5
Ovarian Neoplasms
4
Myoma
4
Lymphoma, Non-Hodgkin
4
Leiomyoma
4
Hemorrhage
4
Head and Neck Neoplasms
4
Glioblastoma
4
Colonic Neoplasms
4
Agnosia
4
Skin Neoplasms
3
Recurrence
3
Rectal Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neurotoxicity Syndromes
3
Neoplasm Metastasis
3
Nasopharyngeal Carcinoma
3
Myelodysplastic Syndromes
3
Multiple Endocrine Neoplasia Type 1
3
Interventions
Indocyanine Green
2
Ileostomy
2
Bioseal
2
Water
1
Tobramycin
1
Tissue Adhesives
1
Surgical Procedures, Operative
1
Surgical Fixation Devices
1
Somatostatin
1
Sodium Chloride
1
Serum Albumin, Human
1
Saline Solution
1
Robotic Surgical Procedures
1
Neomycin
1
Metronidazole
1
Methods
1
Levofloxacin
1
Inulin
1
Fluorescein Angiography
1
Fibrin Tissue Adhesive
1
Esophagectomy
1
Enoxaparin
1
Endoscopy
1
Enbucrilate
1
Diet
1
Congresses as Topic
1
Colistin
1
Ciprofloxacin
1
Cathartics
1
Amphotericin B
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Anastomotic Leak
×
Sodium Chloride
×
Clear all
NCT02682485
2023-04-26
SES-DTA
University of Chicago
Phase 2
Withdrawn